It is defined as decreased sensitivity to insulin-mediated glucose disposal and inhibition of hepatic glucose production (43) and presents as dysfunction of insulin transduction in glucose uptake and utilization in body skeletal muscles, adipocytes and hepatocytes (44), which leads to hyperglycemia, hyperinsulinemia and various disorders. Here, INS is linked to hyperinsulinism.